Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Sirona Biochem Corp
V.SBM
Alternate Symbol(s):
SRBCF
Healthcare
Biotechnology
Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to...
large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSXV:SBM)
New Post
View:
Posts & Comments
Threaded Posts
Prev
...
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
...
Next
(2138)
•••
lscfa
X
View Profile
View Bullboard History
Comment by
lscfa
on Dec 13, 2023 7:46am
RE:GlycoProteMim™
Trademarked in France 2009, expiry 2029.... https://branddb.wipo.int/en/quicksearch/brand/FR502009003687295?sort=score%20desc&start=0&rows=30&asStructure=%7B%22_id%22:%226156%22
...more
(12)
•••
LakeOromocto
X
View Profile
View Bullboard History
Post by
LakeOromocto
on Dec 13, 2023 2:01am
New Investors Welcome
Due your due diligence, here are the facts to date on two great products: TFC1067 signed contract with Abbvie, they are preparing our ingredient for eventual sales around the world and it's a
...more
Level Up Your Trading with BMO InvestorLine’s Enhanced Features
posted Nov 24, 2024 9:00am by
Bank of Montreal
-
|
Features like Multi-Leg Orders, Options Screener, and Strategy Builder will be particularly exciting for traders. They have been designed to be intuitive and user-friendly, regardless of your experience level. Whether you’re a seasoned pro or just starting out, you’ll find these tools easy to navigate and adapt to your investing style. ...read more
(12)
•••
LakeOromocto
X
View Profile
View Bullboard History
Post by
LakeOromocto
on Dec 13, 2023 1:14am
Video on twitter
https://twitter.com/SironaBiochem/status/1734817654471270895?t=_9Tp9bqCsOU1bliKPpHHsw&s=19
(80)
•••
bealert
X
View Profile
View Bullboard History
Post by
bealert
on Dec 12, 2023 10:24pm
Management transparency and accountability.
I see than anonymous sold 145k today at 8 cents. That's quite an insult to Howhee after that impressive news release. If he had any credibility left, the stock should have doubled on
...more
(12)
•••
LakeOromocto
X
View Profile
View Bullboard History
Post by
LakeOromocto
on Dec 12, 2023 6:34pm
GlycoProteMim™
This is the ingredient name, I wonder what the name will be for the cream and maybe more than one product!? Alot more info coming in next few months. Cheers
(9)
•••
Engcan77
X
View Profile
View Bullboard History
Comment by
Engcan77
on Dec 12, 2023 3:05pm
RE:RE:RE:News release = BIG MEH.
Yes, it's about time they took a different angle. Years and years of waiting for other companies to make them some cash flow, that up to now has produced diddly squat. Plus, unless they can come
...more
(101)
•••
biorun
X
View Profile
View Bullboard History
Comment by
biorun
on Dec 12, 2023 2:43pm
RE:RE:News release = BIG MEH.
Not so sure you have this assessment correct. The release suggests otherwise and a little time and space may suggest otherwise as it seems they are taking a different angle on this one.
(72)
•••
MirrorWorldMan
X
View Profile
View Bullboard History
Comment by
MirrorWorldMan
on Dec 12, 2023 2:21pm
RE:News release = BIG MEH.
Most BT's gave their molecules names, nothing special about it at all. Maybe Howie is in his own private Idaho and thinks this is somehow earth shattering. He really needs to get out more. He
...more
(101)
•••
biorun
X
View Profile
View Bullboard History
Comment by
biorun
on Dec 12, 2023 12:57pm
RE:RE:RE:RE:News release = BIG MEH.
How about they give us each a tube for free. Lol
(12)
•••
LakeOromocto
X
View Profile
View Bullboard History
Comment by
LakeOromocto
on Dec 12, 2023 11:44am
RE:RE:RE:News release = BIG MEH.
Imagine one day we investors can finally buy a tube to try ourselves. Hey Sirona can you offer us a discount? GLTA
(38)
•••
Turtle4
X
View Profile
View Bullboard History
Comment by
Turtle4
on Dec 12, 2023 11:31am
RE:RE:News release = BIG MEH.
First we need the news that the scale-up for production has been completed. If that doesn't work, it will all have been for nothing.
(9)
•••
Engcan77
X
View Profile
View Bullboard History
Comment by
Engcan77
on Dec 12, 2023 11:17am
RE:News release = BIG MEH.
The question is, do we want to continue to get "next to nothing" upfront payments for all these products, just to see the company involved sit on them for years and not getting them to
...more
(77)
•••
Pareto8020
X
View Profile
View Bullboard History
Post by
Pareto8020
on Dec 12, 2023 10:04am
News release = BIG MEH.
So they trademarked a compound - whoopie. All that does is create an added expense to a bank account that must already be getting low. If the compound is as spectacular as it seems a
...more
(26)
•••
24minus7
X
View Profile
View Bullboard History
Comment by
24minus7
on Dec 12, 2023 7:42am
RE:Retinol market size
Let's include Botox with an opinion by Bard: Sirona Biochem's GlycoProteMim™ is a novel anti-aging molecule that has the potential to be a viable alternative to Botox. Both GlycoProteMim™ and
...more
Prev
...
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >